202 related articles for article (PubMed ID: 37195771)
1. The Management of Low-Risk Myelodysplastic Syndromes-Current Standards and Recent Advances.
Randall MP; DeZern AE
Cancer J; 2023 May-Jun 01; 29(3):152-159. PubMed ID: 37195771
[TBL] [Abstract][Full Text] [Related]
2. New Approaches to Myelodysplastic Syndrome Treatment.
Bazinet A; Bravo GM
Curr Treat Options Oncol; 2022 May; 23(5):668-687. PubMed ID: 35320468
[TBL] [Abstract][Full Text] [Related]
3. Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter?
Gorshein E; Weber UM; Gore S
Expert Rev Hematol; 2020 Mar; 13(3):233-239. PubMed ID: 32067540
[No Abstract] [Full Text] [Related]
4. Current Therapeutic Landscape in Lower Risk Myelodysplastic Syndromes.
Wang C; Sallman DA
Curr Treat Options Oncol; 2023 May; 24(5):387-408. PubMed ID: 36966266
[TBL] [Abstract][Full Text] [Related]
5. Raising the bar for lower-risk myelodysplastic syndromes.
Venugopal S; Sekeres MA
Leuk Lymphoma; 2023 Jun; 64(6):1082-1091. PubMed ID: 37029589
[TBL] [Abstract][Full Text] [Related]
6. Clinical decision-making and treatment of myelodysplastic syndromes.
Hellström-Lindberg ES; Kröger N
Blood; 2023 Dec; 142(26):2268-2281. PubMed ID: 37874917
[TBL] [Abstract][Full Text] [Related]
7. Optimal sequencing of treatments for patients with myelodysplastic syndromes.
Itzykson R; Fenaux P
Curr Opin Hematol; 2009 Mar; 16(2):77-83. PubMed ID: 19468268
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
Nimer SD
J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
[TBL] [Abstract][Full Text] [Related]
9. How we manage adults with myelodysplastic syndrome.
Fenaux P; Platzbecker U; Ades L
Br J Haematol; 2020 Jun; 189(6):1016-1027. PubMed ID: 31568568
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies in low- and high-risk myelodysplastic syndrome.
Germing U; Schroeder T; Kaivers J; Kündgen A; Kobbe G; Gattermann N
Expert Rev Hematol; 2019 Oct; 12(10):893-908. PubMed ID: 31353975
[No Abstract] [Full Text] [Related]
12. Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS).
Lucero J; Al-Harbi S; Yee KWL
Curr Oncol; 2023 Jun; 30(7):6177-6196. PubMed ID: 37504319
[TBL] [Abstract][Full Text] [Related]
13. Overview of the Management of Higher-Risk Myelodysplastic Syndromes.
Singh A; Carraway HE
Cancer J; 2023 May-Jun 01; 29(3):160-167. PubMed ID: 37195772
[TBL] [Abstract][Full Text] [Related]
14. SOHO State of the Art and Next Questions: Management of Myelodysplastic Syndromes With Deletion 5q.
Talati C; Sallman D; List AF
Clin Lymphoma Myeloma Leuk; 2018 Oct; 18(10):629-635. PubMed ID: 30097406
[TBL] [Abstract][Full Text] [Related]
15. Evolving therapies for lower-risk myelodysplastic syndromes.
Bewersdorf JP; Zeidan AM
Ann Hematol; 2020 Apr; 99(4):677-692. PubMed ID: 32078008
[TBL] [Abstract][Full Text] [Related]
16. Treatment of MDS.
Platzbecker U
Blood; 2019 Mar; 133(10):1096-1107. PubMed ID: 30670446
[TBL] [Abstract][Full Text] [Related]
17. Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.
Sekeres MA; Maciejewski JP; Giagounidis AA; Wride K; Knight R; Raza A; List AF
J Clin Oncol; 2008 Dec; 26(36):5943-9. PubMed ID: 19018091
[TBL] [Abstract][Full Text] [Related]
18. Lenalidomide in myelodysplastic syndromes: where do we go from here?
Sirulnik LA; Stone RM
Curr Hematol Malig Rep; 2008 Jan; 3(1):5-9. PubMed ID: 20425440
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS).
Almeida A; Fenaux P; List AF; Raza A; Platzbecker U; Santini V
Leuk Res; 2017 Jan; 52():50-57. PubMed ID: 27883945
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management.
Garcia-Manero G
Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
